source
- Pfizer exec says China's biotech growth will decelerate as firms hit R&D frontierAndrew Baum of Pfizer told Endpoints News that China's rapid biotech progress is expected to slow as companies move into more advanced research and development. He explained that as Chinese firms…
- Senior staff purchase company shares, filing 16/2026 shows insider buyingThe company released a corporate announcement stating that several senior employees have bought shares of the firm. The filing, identified as 16/2026, does not provide details on the number of sha…